SITC Corporate Memberships

Our corporate membership program is designed to accelerate immuno-oncology breakthroughs by fostering communication between industry partners, SITC leaders and pharmaceutical, technology and investments firms.

Corporate Advisory Council Members

Astellas
AstraZeneca
BMS
Gilead
Kite
Novartis

Corporate Membership

SITC Corporate Membership Benefits

A SITC corporate membership provides organizations in the field of cancer immunotherapy and cancer research a forum to address common issues impacting the field with the goal of improving cancer patient outcomes.

Industry Roundtable

Engage with industry leaders to address key hurdles in the field, and participate in meetings organized around issues that affect your interests.

Private Meeting with SITC Leadership

Leverage exclusive access to SITC Leadership through a private meeting each year at a location and time amenable to both parties.

Priority Access to SITC Think Tanks

Enjoy VIP invites and access to SITC Think Tanks. Past examples include the Leveraging Biomarkers Workshop, Surrogate Endpoints Summit and Release Criteria Workshop. Additional costs will apply.

Check-ins with SITC Staff

Meet with our Executive Director and Director of Development to discuss strategic partnerships, provide feedback on collaborative initiatives and align mutual goals for advancing cancer immunotherapy.

Annual Corporate Membership Dues

SITC is proud to be a broker of new relationships among the individuals leading the next generation of cancer immunotherapy research.

Contact us about this tier

Employee size Annual dues
< 250 employees $10,000
251–1,000 employees $25,000
1,001–5,000 employees $40,000
5,001–10,000 employees $55,000
10,001–20,000 employees $80,000
> 20,000 employees $100,000